Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Azathramycin A: Structural Insights and Biophysical Decision
2026-05-13
Explore the scientific foundation of Azathramycin A as a macrolide antibiotic, with an emphasis on structural-functional insights and biophysical screening considerations for tuberculosis research. This article uniquely connects chemical stability, degradation pathways, and optimal experimental design.
-
Cimetidine in Translational Assays: Distinct H2R Modulation
2026-05-13
Explore Cimetidine as a histamine-2 receptor antagonist with a unique partial agonist profile, highlighting its advanced applications in translational research—from gastrointestinal cancer to cutting-edge blood-brain barrier models. This article delivers in-depth protocol guidance, scientific insights, and strategic positioning beyond existing content.
-
Fe3O4@ZIF-8 Nanoparticles: Antibacterial and Osteogenic Acti
2026-05-12
This study demonstrates that Fe3O4@ZIF-8 core–shell nanoparticles can simultaneously combat infection and promote bone regeneration in jaw osteomyelitis. By leveraging pH-responsive Zn2+ release and magnetic field synergy, the platform offers a dual-function nanomaterial approach with translational potential for chronic bone infection therapy.
-
5-HT3 Antagonists Inhibit Renal OCT2 and MATE1: In Vitro Evi
2026-05-12
This study rigorously investigates the in vitro inhibition of renal OCT2 and MATE1 transporters by five clinically relevant 5-HT3 receptor antagonists, notably including palonosetron hydrochloride. The findings provide key quantitative insight into drug–transporter interactions, informing both experimental design and clinical considerations in antiemetic therapy for cancer patients.
-
Vascular Effects of JAK Inhibitors in Endothelial Inflammati
2026-05-11
This study systematically compared the vascular effects of different JAK inhibitors, including tofacitinib citrate, on human endothelial cells exposed to pro-inflammatory cytokines. It reveals both common anti-inflammatory actions and distinct profiles regarding endothelial dysfunction and coagulation, informing the design and interpretation of immune regulation and cardiovascular risk research.
-
Thiothixene Stimulates Macrophage Efferocytosis via Arginase
2026-05-11
The referenced study demonstrates that thiothixene, a typical antipsychotic agent, robustly enhances efferocytosis and continual clearance of apoptotic and lipid-laden cells by macrophages via induction of Stra6l and Arginase 1. These findings connect dopamine signaling modulation to immune clearance mechanisms, offering translational potential for chronic inflammatory conditions.
-
Escitalopram for Antidepressant Research: Protocols & Insigh
2026-05-10
Leverage high-purity Escitalopram from APExBIO to power advanced antidepressant and anxiolytic research. This guide delivers actionable experimental workflows, troubleshooting strategies, and data-driven protocol parameters to help you maximize reproducibility and mechanistic insight in serotonergic signaling studies.
-
Cefotaxime: Optimizing AMR Research with Third-Generation Ce
2026-05-09
Cefotaxime stands out in antimicrobial resistance research by combining broad-spectrum efficacy with robust beta-lactamase resistance. This guide details experimental workflows, troubleshooting strategies, and protocol enhancements to accelerate breakthroughs in bacterial infection models.
-
Ciclesonide in Experimental Asthma: Protocols and Troublesho
2026-05-08
Ciclesonide, a prodrug glucocorticoid, offers robust, targeted anti-inflammatory action for respiratory research models. This article delivers actionable workflows, troubleshooting strategies, and the latest insights from ERAD-hijacking degradation technology, helping researchers maximize reproducibility and efficacy in asthma and allergic rhinitis studies.
-
Tropisetron Hydrochloride: 5-HT3 Receptor Antagonist in Mode
2026-05-08
Tropisetron Hydrochloride from APExBIO empowers translational neuroscience and renal transporter experiments with its dual 5-HT3 antagonist and α7-nicotinic agonist profile. This guide translates recent breakthroughs into actionable protocols and troubleshooting strategies for reproducible, high-impact serotonin receptor signaling research.
-
RSV NS3 Modulates Pathogenicity via Host SnRK3.25 Signaling
2026-05-07
Zhuang et al. reveal how Rice stripe virus (RSV) NS3 protein exploits host SnRK3.25-CBL1/3-RBOHF signaling to dynamically adjust viral pathogenicity and transmission. This mechanistic insight into virus-host-vector co-survival strategies highlights new directions for understanding plant-virus interactions and potential antiviral intervention points.
-
Escitalopram for Antidepressant Research: Bench to Protocols
2026-05-07
Escitalopram (Lexapro) stands out in antidepressant and anxiolytic research for its unparalleled serotonergic selectivity and reproducibility. This guide translates bench evidence and clinical insights into actionable workflows, troubleshooting, and protocol optimization for modern neuroscience labs.
-
Palonosetron Hydrochloride: Next-Gen 5-HT3 Antagonism in Onc
2026-05-06
Explore the unique pharmacology of Palonosetron hydrochloride, a highly selective 5-HT3 receptor antagonist, and discover advanced assay strategies and translational oncology applications. This article integrates core scientific evidence with actionable precision for cancer research.
-
Magnetic Stimulation Modulates GABRE to Reverse Schizophreni
2026-05-06
This study demonstrates that targeted magnetic stimulation of the left prelimbic cortex in mice downregulates the GABAA receptor epsilon subunit, leading to the reversal of schizophrenia-like behaviors and synaptic deficits. The findings reveal Gabre and its molecular circuitry as promising, precise targets for noninvasive neuromodulation in schizophrenia research.
-
Fenipentol Beyond Choleresis: Molecular Modulation and Trans
2026-05-05
Delve into the molecular mechanisms of Fenipentol (1-Phenyl-1-pentanol) as a research tool for metabolic and fibrotic pathway modulation. This article uniquely bridges advanced receptor biology with practical assay design for gastrointestinal and hepatic studies.